Trial Identifier: | D081LR00003 |
Sponsor: | AstraZeneca |
NCTID:: | NCT04962880 |
Start Date: | April 2021 |
Primary Completion Date: | April 2022 |
Study Completion Date: | April 2022 |
Condition: | Prostate Cancer |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.